The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
Karl Kaufmann, an emergency room physician at Washington's Valley Medical Center, spends a lot of time at the end of a shift doing administrative work, like typing words and checking boxes into electronic medical records.
But recently, he's been testing out a virtual medical scribe called SayKara.
SayKara was developed by a group of former employees from companies like speech recognition giant Nuance and Amazon. The team is based in Seattle and is launching this week after several years quietly developing the technology and securing a $2.5 million seed round from local investment firm Madrona Venture Group.
"I use SayKara in two ways, both to recap a patient visit and to incorporate the pertinent details of a patient interaction into the medical record," said Kaufmann. Similarly to Amazon Alexa, SayKara starts working when a physician says a hot word, like "OK Kara" or taps on the app that runs on iOS devices, including iPhone and iPad.
Kaufmann was one of the first to try out SayKara, which aims to be an alternative to human scribes and existing dictation tools like Nuance's Dragon. The goal is to accurately transcribe audio to text, parse the information to make it structured, and insert it cleanly into an electronic health record.
Voice is rapidly becoming big business in health care, as medical systems look for new ways to help doctors focus on the patient interaction, rather than the computer. Studies have shown that doctors today spend about a quarter of their time on the patient visit, with nearly half on desk work and charting in the electronic health record.
As a result, hospitals are already tinkering with Amazon's voice technology Alexa. And businesses like Augmedix are leveraging Google's Glass hardware to offer electronic health record support with a remote scribe.
But SayKara says it's taking a different approach. Unlike Amazon, it is narrowly focused on the health-care space. And unlike more established competitors like Augmedix, it doesn't rely on human transcribers, which are expensive and take months to train.
SayKara CEO Harjinder Sandhu says the first inspiration for the technology was Amazon Alexa, but that the team realized early on it needed to focus on the needs of the medical sector to get it right. In order to sell to hospitals, SayKara needs to meet compliance, security and privacy requirements, and ensure that it doesn't make seemingly small mistakes that can actually have an enormous effect (a difference is "hypo" versus "hyper").
"The hurdles in health care are very high," admits Sandhu.
But Sandhu believes that the current technology is good enough for physicians to use. "We're taking the state of the art in speech recognition and machine learning and we're applying it," he explained. "The key is to couple it with deep knowledge of how physicians work and the information that is relevant to them."
The company hasn't figured out a price yet, but Sandhu maintains that it cost a fraction of a human scribe.
Ralph Pascualy, former CEO of Swedish Medical Group, is one of the first to sign up to use the tool. In his view, so much of his doctors' time is wasted in medical records that any company that can eat "even halfway into the problem" is worth the cost. He also appreciates SayKara's approach in not claiming to replace doctors, but to help them with specific challenges.
"Unlike some AI tools, this company isn't attempting to boil the ocean," he said. "I think physicians will be more comfortable with that."